The myelodysplastic syndromes: Predictive value of eight prognostic systems in 143 cases from a single institution

Haematologica

Volumn 84, Issue 1, 1999, Pages 12-16

  Balduini, Carlo Luigi ^a   Guarnone, Roberta ^a   Pecci, Alessandro ^a   Centenara, Esther ^a   Invernizzi, Rosangela ^a   Ascari, Edoardo ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

FAB classification; Myelodysplastic syndromes; Prognostic systems; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC MYELOMONOCYTIC LEUKEMIA; DISEASE CLASSIFICATION; HIGH RISK PATIENT; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; PREDICTION; PROGNOSIS; REFRACTORY ANEMIA; SCORING SYSTEM; SURVIVAL RATE;

EID: 0032884526     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Aul C, Gattermann N, Schneider W. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes. Br J Haematol 1992; 82:358-67.
2. Demuynck H, Verhoef GE, Zachee P, et al. Treatment of patients with myelodysplastic syndromes with allo-geneic bone marrow transplantation from genotypically HLA-identical sibling and alternative donors. Bone Marrow Transplant 1996; 17:745-51.
3. Anderson JE, Anasetti C, Appelbaum FR, et al. Unrelated donor marrow transplantation for myelodysplasia (MDS) and MDS-related acute myeloid leukaemia. Br J Haematol 1996; 93:59-67.
4. Bennet JM, Catovsky D, Daniel MT, et al. Proposal for the classification of the myelodysplastic syndromes. Br J Haematol 1992; 51:189-99.
5. Rosati S, Mick R, Xu F, et al. Refractory cytopenia with multilineage dysplasia: further characterization on an "unclassifiable" myelodysplastic syndrome. Leukemia 1996; 10:20-6.
6. Mufti GJ, Stevens JR, Oscier DG, Hamblin TJ, Machin D. Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol 1985; 59:425-33.
7. 7. Sanz GF, Sanz MA, Vallespi T, et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989; 74:395-408.
8. Goasguen JE, Gerard R, Bizet M, et al. Prognostic factors of myelodysplastic syndromes - A simplified 3-D scoring system. Leuk Res 1990; 14:255-62.
9. Morra E, Lazzarino M, Castello A, et al. Risk assessment in myelodysplastic syndromes: value of clinical, hematologic and bone marrow histologic findings at presentation. Eur J Haematol 1990; 45:94-8.
10. Morel P, Hebbar M, Lai JL, Duhamel A. Cytogenetic analysis has strong prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases. Leukemia 1993; 7:1315-23.
11. Greenberg P, Cox C, LeBeau MM, et al. International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 1977; 86:2079-88.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
13. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Canc Chem Rep 1966; 50:163-70.
14. Cox DR. Regression models and life tables. J Royal Stat Soc 1972; 34:187-220.
15. Sanz GF, Sanz MA. Prognostic factors in myelodysplastic syndromes. Leuk Res 1992; 16:77-86.
16. Sanz GF, Sanz MA, Greenberg PL. Prognostic factors and scoring systems in myelodysplastic syndromes. Haematologica 1998; 83:358-68.